Madame Bioscience PCL (BKK:MADAME)
0.8300
0.00 (0.00%)
At close: Aug 10, 2026
Madame Bioscience PCL Financials Overview
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,528 | 1,478 | 2,123 | 2,302 | 2,228 | 1,862 |
Revenue Growth | -21.22% | -30.39% | -7.78% | 3.35% | 19.61% | 22.79% |
Gross Profit Gross Profit Growth | 416.04 | 321.76 | 359.99 | 296.44 | 81.33 | 301.34 |
Operating Income Operating Income Growth | -401.02 | -185.43 | 42.34 | -166.26 | -385.44 | -110.1 |
Net Income Net Income Growth | -160.62 | 45.77 | -331.63 | -405.81 | -422.31 | -152.43 |
Earnings Per Share EPS Growth | -0.21 | 0.06 | -0.54 | -0.66 | -0.70 | -0.38 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Business Other Business Growth | 0.72 | 0.99 | 2.04 | 2.66 | 4.48 | 17.28 |
Selling Skincare Products Business Selling Skincare Products Business Growth | - | 197.02 | - | - | - | - |
Packaging Business Packaging Business Growth | - | 83.2 | 957.56 | 847.96 | 845.1 | 659.43 |
Food Business Food Business Growth | 1,265 | 1,272 | 1,479 | 1,776 | 1,740 | 1,198 |
Elimination Elimination Growth | -30.22 | -75.32 | -315.66 | -324.48 | -361.58 | -12.65 |
Total Total Growth | 1,528 | 1,478 | 2,123 | 2,302 | 2,228 | 1,862 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 135.04 | 193.81 | 80.62 | 34.76 | 253.34 | 52.39 |
Total Debt Total Debt Growth | 216.57 | 243.62 | 614.14 | 819.66 | 921.92 | 323.17 |
Net Cash (Debt) Net Cash Growth | -81.52 | -49.81 | -533.52 | -784.91 | -668.57 | -270.78 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.11 | -0.06 | -0.86 | -1.28 | -1.11 | -0.68 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1.23 | 39.72 | 227.01 | 71.98 | -163.44 | -98.48 |
Capital Expenditures CapEx Growth | -42.74 | -41.49 | -15.39 | -39.61 | -144.02 | -206.38 |
Free Cash Flow Free Cash Flow Growth | -41.5 | -1.77 | 211.62 | 32.37 | -307.46 | -304.86 |
Free Cash Flow Growth | - | - | 553.65% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 27.22% | 21.77% | 16.96% | 12.88% | 3.65% | 16.18% |
Operating Margin | -26.24% | -12.55% | 1.99% | -7.22% | -17.30% | -5.91% |
Pretax Margin | -10.42% | 3.38% | -15.52% | -17.79% | -19.94% | -10.07% |
Profit Margin | -10.51% | 3.10% | -15.62% | -17.63% | -18.96% | -8.19% |
FCF Margin | -2.72% | -0.12% | 9.97% | 1.41% | -13.80% | -16.37% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 12.36 | - | - | - | - |
P/FCF Ratio | - | - | 3.57 | 35.16 | - | - |
PS Ratio | 0.44 | 0.38 | 0.36 | 0.49 | 0.93 | 1.40 |